From: Neuropathy-specific alterations in a Mexican population of diabetic patients
ND | DNN | DShP | DSHP | DMN | |
---|---|---|---|---|---|
Triglycerides (mg/dl) | 116 (86–159) b | 166 (106–203) ab | 144 (123–198) a | 153 (116–219) a | 171 (129–232) a |
(N = 363) | (N = 20) | (N = 109) | (N = 50) | (N = 40) | |
Cholesterol (mg/dl) | 180 (149–207) a | 153 (132–201) a | 167 (147–198) a | 190 (156–213) a | 172 (162–214) a |
(N = 363) | (N = 20) | (N = 109) | (N = 50) | (N = 40) | |
HDL-Cholesterol (mg/dl) | 46 (38–57) a | 42 (38–50) ab | 42 (35–50) b | 43 (34–53) ab | 47 (38–57) ab |
(N = 361) | (N = 19) | (N = 108) | (N = 50) | (N = 40) | |
LDL-Cholesterol (mg/dl) | 119 (98–140) a | 113 (87–148) a | 114 (96–138) a | 130 (107–159) a | 112 (95–132) a |
(N = 359) | (N = 19) | (N = 107) | (N = 50) | (N = 40) | |
HDL / LDL | 0.39 (0.31–0.51) a | 0.39 (0.28–0.53) ab | 0.35 (0.30–0.45) ab | 0.32 (0.27–0.39) b | 0.37 (0.30–0.50) ab |
(N = 359) | (N = 19) | (N = 107) | (N = 50) | (N = 40) |